Abstract
S1617 Elevations in Total Serum Bile Acids During Bulevirtide Treatment Show No Association With Adverse Events of Interest in Patients With Chronic Hepatitis Delta: An Integrated Safety Analysis of 48-Week Data
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have